scholarly journals Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l

2003 ◽  
Vol 18 (2) ◽  
pp. 417-422 ◽  
Author(s):  
E.C. Larsen
Keyword(s):  
Cancer Survivors ◽  
Childhood Cancer ◽  
Ovarian Reserve ◽  
Childhood Cancer Survivors ◽  
Diminished Ovarian Reserve ◽  
Menstrual Cycles

scholarly journals Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence

2018 ◽  
Vol 36 (2) ◽  
pp. 341-348 ◽  
Author(s):  
Edgardo Somigliana ◽  
Monica Terenziani ◽  
Francesca Filippi ◽  
Alice Bergamini ◽  
Fabio Martinelli ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Childhood Cancer ◽  
Ovarian Reserve ◽  
Childhood Cancer Survivors

scholarly journals Genetic variation may modify ovarian reserve in female childhood cancer survivors

2013 ◽  
Vol 28 (4) ◽  
pp. 1069-1076 ◽  
Author(s):  
W. van Dorp ◽  
M.M. van den Heuvel-Eibrink ◽  
L. Stolk ◽  
R. Pieters ◽  
A.G. Uitterlinden ◽  
...  
Keyword(s):  
Genetic Variation ◽  
Cancer Survivors ◽  
Childhood Cancer ◽  
Ovarian Reserve ◽  
Childhood Cancer Survivors

scholarly journals Serum Anti-Müllerian Hormone Levels and Risk of Premature Ovarian Insufficiency in Female Childhood Cancer Survivors: Systematic Review and Network Meta-Analysis

Cancers ◽  
2021 ◽  
Vol 13 (24) ◽  
pp. 6331
Author(s):  
Marco Torella ◽  
Gaetano Riemma ◽  
Pasquale De Franciscis ◽  
Marco La Verde ◽  
Nicola Colacurci
Keyword(s):  
Systematic Review ◽  
Cancer Survivors ◽  
Childhood Cancer ◽  
Ovarian Reserve ◽  
Meta Analysis ◽  
Childhood Cancer Survivors ◽  
Premature Ovarian Insufficiency ◽  
Control Group ◽  
Ovarian Insufficiency ◽  
Increased Risk

Background: Female childhood cancer survivors (CCS) might have impaired ovarian reserves, especially after alkylating agents or radiotherapy. The purpose of this systematic review and network meta-analysis is to evaluate the role of serum anti-Müllerian hormone (AMH) for ovarian reserve screening and the risk of premature ovarian insufficiency (POI) according to the subtype of childhood cancer. (2) Methods: PRISMA-NMA guidelines were followed. We carried out a network meta-analysis based on a random effects model for mixed multiple treatment comparisons to rank childhood cancers effects on fertility by surface under the cumulative ranking curve (SUCRA). Studies were selected only if they had an age-matched control group. Quality assessment was performed using Newcastle–Ottawa Scale. The co-primary outcomes were mean AMH levels and the incidence of POI. (3) Results: A total of 8 studies (1303 participants) were included. Women treated for a neuroblastoma during infancy were more likely to be ranked first for impaired AMH levels (SUCRA = 65.4%), followed by mixed CCS (SUCRA = 29.6%). The greatest rates of POI were found in neuroblastoma survivors (SUCRA = 42.5%), followed by acute lymphoid leukemia (SUCRA = 26.3%) or any other neoplasia (SUCR A= 20.5%). (4) Conclusions: AMH represents a trustworthy approach for ovarian reserve screening. Direct and indirect comparisons found no differences in mean AMH levels and POI risk between subtypes of CCS and healthy controls. SUCRA analysis showed that female neuroblastoma survivors were more at risk for reduced serum AMH levels and increased risk of POI.

scholarly journals Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone

2008 ◽  
Vol 24 (4) ◽  
pp. 982-990 ◽  
Author(s):  
S. Lie Fong ◽  
J.S.E. Laven ◽  
F.G.A.J. Hakvoort-Cammel ◽  
I. Schipper ◽  
J.A. Visser ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Childhood Cancer ◽  
Ovarian Reserve ◽  
Childhood Cancer Survivors

Examining neurodevelopmental outcomes among bilingual childhood cancer survivors

2008 ◽  
Author(s):  
Lauren A. Mikula ◽  
Julie Snyder ◽  
Anai M. Cuadra ◽  
Maria L. Goldman ◽  
Wendy E. Sulc ◽  
...  
Keyword(s):  
Cancer Survivors ◽  
Childhood Cancer ◽  
Childhood Cancer Survivors ◽  
Neurodevelopmental Outcomes
Sign in / Sign up

Export Citation Format

Share Document